ZURA Zura Bio Ltd Gross Profit Rate

The gross profit margin on the GURU.Markets chart demonstrates the efficiency of the Zura Bio antibody patent ecosystem. The 0.00 level is a current figure confirming the monetization potential of rights to treat rare pathologies. The company's stable capital ensures research independence, creating a foundation for the future licensing of innovative molecules in alliance with pharmaceutical behemoths.
Financial and market metric breakdowns for Zura Bio Ltd (ZURA)

The stability of fundamental multiples for Zura Bio Limited (ZURA) determines the business's resilience to market volatility and its potential for long-term capitalization growth. Quarterly gross margin measures the profit share after deducting direct production costs, reflecting the efficiency of cost management amid geopolitical risks affecting the cost of reagents and the expense of conducting international clinical trials.